Published on: April 19, 2019 at 07:00PM
Conditions: Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic
Interventions: Drug: Metformin; Drug: Sulfonylurea; Drug: DPP-4 inhibitor; Drug: SGLT2 inhibitor; Drug: GLP1 receptor agonist
Sponsors: Weill Medical College of Cornell University; Patient-Centered Outcomes Research Institute
Not yet recruiting
No comments:
Post a Comment